v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 184,007
Prepaid expenses and other current asset 525,677
Total Current Assets 709,684
Deferred offering costs 165,778
Cash and marketable securities held in Trust Account 253,042,565
Total Assets 253,752,249 165,778
Current liabilities    
Accounts payable and accrued expenses 3,230,476
Accrued offering costs 318,589 140,778
Promissory note — related party 5,000
Total Current Liabilities 3,549,065 145,778
Warrant Liabilities 29,639,725
Deferred underwriting fee payable 8,855,000
Total Liabilities 42,043,790 145,778
Commitments
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 25,300,000 and no shares subject to redemption at $10.00 per share as of September 30, 2021 and December 31, 2020, respectively 253,000,000
Shareholders’ (Deficit) Equity    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of September 30, 2021 and December 31, 2020
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 6,325,000 shares issued and outstanding as of September 30, 2021 and December 31, 2020 633 633
Additional paid-in capital 24,367
Accumulated deficit (41,292,174) (5,000)
Total Shareholders’ (Deficit) Equity (41,291,541) 20,000
Total Liabilities and Shareholders’ (Deficit) Equity $ 253,752,249 $ 165,778

Source